Factors associated with relapse after bone marrow transplantation for myelodysplasia in multivariate analysis
Variables . | Relative risk (95% CI) . | P . |
---|---|---|
Blasts in bone marrow before transplantation4-150 | ||
(1) Less than 5% | 1.00 | P‡overall < .0001 |
(2) 5%-20% | 2.9 (1.7-4.9) | P12 < .0001 |
(3) More than 20% | 6.3 (3.4-11.6) | P13 < .0001 |
(4) Unknown | 2.5 (1.3-4.9) | P140 = .0082 |
IPSS at diagnosis4-153 | ||
(1) High risk | 1.00 | |
(2) Intermediate/low risk | 0.5 (0.3-0.8) | P12 = .0061 |
(3) Unknown | 0.4 (0.2-0.7) | P13 = .0033 |
GVHD prophylaxis | ||
(1) Non T-cell depletion | 1.00 | |
(2) T-cell depletion | 1.8 (1.0-3.2) | P = .0361 |
Variables . | Relative risk (95% CI) . | P . |
---|---|---|
Blasts in bone marrow before transplantation4-150 | ||
(1) Less than 5% | 1.00 | P‡overall < .0001 |
(2) 5%-20% | 2.9 (1.7-4.9) | P12 < .0001 |
(3) More than 20% | 6.3 (3.4-11.6) | P13 < .0001 |
(4) Unknown | 2.5 (1.3-4.9) | P140 = .0082 |
IPSS at diagnosis4-153 | ||
(1) High risk | 1.00 | |
(2) Intermediate/low risk | 0.5 (0.3-0.8) | P12 = .0061 |
(3) Unknown | 0.4 (0.2-0.7) | P13 = .0033 |
GVHD prophylaxis | ||
(1) Non T-cell depletion | 1.00 | |
(2) T-cell depletion | 1.8 (1.0-3.2) | P = .0361 |